‘Ayurvedic medicines undergo rigorous 3-5 years of trials before market entry’


In a recent statement to a prominent media house, Vicram Sharma, Director of the esteemed Baidyanath Group, a century-old Ayurveda company, shed light on the meticulous process behind the development and introduction of Ayurvedic medicines to the market.


Sharma emphasized the traditional nature of their formulations, including rasayans and bhasmas, which have withstood centuries of use since the time of Charaka. These time-tested formulations are not experimental drugs, with ingredients and processes faithfully following ancient texts. The proprietary formulae undergo a rigorous journey, starting with preparation under the supervision of trained Vaids.


The process further involves scrutiny by government laboratories to screen for toxicity. Subsequently, clinical trials take place at the Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University. Additionally, the company conducts trials on volunteers at their charitable Dharmarth clinics in Patna. Only after a thorough 3-5 years of trials does a product enter mass production.


Sharma highlighted the evolving market dynamics, noting the shift from predominantly rural markets to an increasing demand in urban areas. To meet the needs of this growing consumer base, Ayurveda products are now targeting urban-specific health concerns such as anxiety, insomnia, weight loss, and pollution-related ailments.


Addressing the broader perspective of Ayurveda, Sharma expressed the need for its inclusion in school curriculums. Proposing workshops and seminars, he emphasized the importance of preserving indigenous knowledge systems. Children, he suggests, should acquire a practical understanding of medicinal properties in common herbs, connecting human health to the environment and fostering a holistic Ayurvedic perspective.




Managed by ayurvedamagazine.org

Leave a Comment: